Who are we?
We are a Danish ISO13485 certified medtech company located in Copenhagen. Our focus is to automate and digitize respiratory care.
We pride ourselves on our extensive collaboration with patients, healthcare institutions, and research centers on a global scale, all in pursuit of innovative and cutting-edge solutions that redefine respiratory care.
At O2matic, our mission is both to relieve the healthcare staff and improve the quality of treatment for patients in oxygen therapy.
Our journey began in 2010 when we started to question the status quo of manual oxygen therapy control, a technology which remained mostly unchanged for over a century. This was the spark that ignited our commitment to modernize this essential aspect of healthcare.
By 2013, we reached a significant milestone, thanks to the invaluable support of the Capital Region of Denmark. We successfully developed our first prototype, setting the stage for a proof-of-concept that showcased the immense potential of automatic oxygen therapy.
In 2016, we secured a grant from the Innovation Fund Denmark, enabling us to obtain the CE mark for our first device PRO 100 designed for hospital use. This marked a pivotal moment in our journey, which signified the readiness of our innovative solution.
Subsequently, in 2017, the company O2matic was officially established, beginning our journey to improving respiratory care and patient outcomes.
Our commitment to safety and efficacy was emphasized in 2018 when our safety study was published, reaffirming our commitment to delivering solutions that prioritize the well-being of patients. The results from the safety study have now been confirmed in several studies.
In 2019, our first respiratory solution, PRO 100, was CE marked by TÜV SÜD, marking a significant milestone in our journey to provide safe and effective medical devices for respiratory care.
Our commitment to safety and efficacy was emphasized in 2018 when our safety study was published, reaffirming our commitment to delivering solutions that prioritize the well-being of patients. The results from the safety study have now been confirmed in several studies
In 2020 we were honored with the prestigious Innovation Fund’s Grand Solution Award, a testament to our significant contributions to the healthcare industry (Read mor e here). Simultaneously, we received the European Commission’s Seal of Excellence, for our effort and innovation in the medtech field.
In 2021, we continued our journey of progress by CE marking and launching O2matic Connectivity, a transformative advancement that connects patients at home to their oxygen therapy needs like never before.
The year 2022 was marked by significant recognition as we were honored with the Microsoft Digital Transformation Award and featured in the Financial Times article, “Meet the Innovators Using AI to Ease One of the World’s Biggest Healthcare Burdens.” Read it here.
From my own personal experience of using a manual oxygen flowmeter and then an O2matic automated oxygen machine, I would unequivocally recommend the O2matic for anyone with any breathing issues, of any kind.
We believe these devices could significantly increase patient safety, provide patients with additional reassurance and bring the additional benefit of more quickly ‘weaning’ patients off their oxygen flow needs, shortening their length of stay.
– Link to article here.
We phased out a patient from 10 l of O2 to 0 l, in 2 hours using O2matic. Something that can usually take several days.
We had the vaccination programme, but [the O2matic] was the biggest reason staff sickness rates fell.
We are using the O2Matic at the moment on our COPD patients who need tight targeted oxygen monitoring and it is proving useful. It is a great device and very happy with it at the moment.
I found that the staff was thrilled. I especially remember a patient who always desaturated when she had to get out of bed – but even managed toilet visits after she got the robot.
I feel safe with the oxygen robot. Can I take it home for use with my home oxygen?
Our experience so far has been, that the risk of severe desaturation (acute oxygen depletion) in patients, is reduced markedly when using the O2matic devices, as compared to conventional solutions… Additionally, the workload for the ward nurses, seems to be much reduced.
GLOBAL PRODUCT MANAGER